| First Author | Liu X | Year | 2021 |
| Journal | Diabetes | PubMed ID | 34957476 |
| Mgi Jnum | J:319885 | Mgi Id | MGI:6864430 |
| Doi | 10.2337/db20-1208 | Citation | Liu X, et al. (2021) Specific Deletion of CASK in Pancreatic beta Cells Affects Glucose Homeostasis and Improves Insulin Sensitivity in Obese Mice by Reducing Hyperinsulinemia Running Title: beta Cell CASK Deletion Reduces Hyperinsulinemia. Diabetes |
| abstractText | Calcium/calmodulin-dependent serine protein kinase (CASK) is involved in the secretion of insulin vesicles in pancreatic beta-cells. The present study revealed a new in vivo role of CASK in glucose homeostasis during the progression of type 2 diabetes mellitus (T2DM). A Cre-loxP system was used to specifically delete the Cask gene in mouse beta-cells (betaCASKKO), and the glucose metabolism was evaluated in betaCASKKO mice fed a normal chow diet (ND) or a high-fat diet (HFD). ND-fed mice exhibited impaired insulin secretion in response to glucose stimulation. Transmission electron microscopy showed significantly reduced numbers of insulin granules at or near the cell membrane in the islets of betaCASKKO mice. By contrast, HFD-fed betaCASKKO mice showed reduced blood glucose and a partial relief of hyperinsulinemia and insulin resistance when compared to HFD-fed wildtype mice. The IRS1/PI3K/AKT signaling pathway was upregulated in the adipose tissue of HFD-betaCASKKO mice. These results indicated that knockout of the Cask gene in beta cells had a diverse effect on glucose homeostasis: reduced insulin secretion in ND-fed mice, but improves insulin sensitivity in HFD-fed mice. Therefore, CASK appears to function in the insulin secretion and contributes to hyperinsulinemia and insulin resistance during the development of obesity-related T2DM. |
